SCIRHOM
SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academic and industry scientists with profound experience in antibody development.
SCIRHOM
Social Links:
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.scirhom.com
Total Employee:
1+
Status:
Active
Contact:
+49 (0)89 614 2412-31
Email Addresses:
[email protected]
Total Funding:
15 M EUR
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Current Employees Featured
Founder
Investors List
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - SciRhom
Hospital for Special Surgery
Hospital for Special Surgery investment in Seed Round - SciRhom
Official Site Inspections
http://www.scirhom.com Semrush global rank: 5.34 M Semrush visits lastest month: 1.56 K
- Host name: sh23146.ispgateway.de
- IP address: 92.205.212.82
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
More informations about "SciRhom"
SciRhom - Crunchbase Company Profile & Funding
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.See details»
SciRhom - LinkedIn
SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel …See details»
SciRhom Company Profile 2024: Valuation, Funding & Investors
SciRhom General Information Description. Developer of therapeutic antibodies designed to improve autoimmune disease therapies. The company creates antibodies against iRhom2, a …See details»
SciRhom announces changes to the management team and the …
SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the …See details»
SciRhom - Overview, News & Competitors | ZoomInfo.com
To date, SciRhom has secured about EUR 7 million in seed funding from the High-Tech Gruenderfonds (HTGF), HSS and private investors. Read More. View Company Info for Free. …See details»
SciRhom secures $70m to develop autoimmune …
Jul 9, 2024 German biopharmaceutical company SciRhom has secured €63m ($70m) in a Series A funding round to expedite the development of iRhom2-targeting therapeutics for autoimmune diseases. The significant financial …See details»
Munich, Germany, December 15, 2021 - SciRhom GmbH
Dec 15, 2021 To date, SciRhom has successfully acquired seed funding from the High-Tech Gruender-fonds (HTGF) and private investors. For further information, please visit …See details»
SciRhom - Funding, Financials, Valuation & Investors - Crunchbase
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases. Search Crunchbase. ... How much funding has this …See details»
SciRhom receives approval for first clinical trial application
In parallel to transitioning into a clinical-stage drug development organization, SciRhom has established a comprehensive preclinical pharmacology and toxicology data package for the …See details»
SciRhom (SciRhom GmbH) - Startbase
HTGF Blog: SciRhom – 63 Mio. EUR Serie A-Finanzierung Gegen den Strom – HTGF-Portfoliofirma SciRhom mit 63 Mio. EUR Serie A-Finanzierung für Mut belohnt Im Juli noch eine der größten Finanzierungsrunden in der deutschen …See details»
Novel Drug Candidate Based on HSS Research Secures $70M …
SciRhom GmbH, a biotech startup co-founded by Hospital for Special Surgery (HSS), recently secured a 63 million euro (US$70 million) Series A financing round to support the clinical …See details»
SciRhom Secures EUR 63 Million Series A Financing Round to …
Jul 9, 2024 SciRhom Leadership Team (2024) From left to right: Dr. Jens Ruhe, Managing Director and Chief Operating Officer - Dr. Jan Poth, Managing Director and Chief Executive …See details»
SciRhom Announces Changes to The Management Team and The …
Nov 18, 2021 Baiker fulfills a key role in shaping the corporate strategy to grow SciRhom’s organization and infrastructure. Hans-Ulrich Rabe rounds off the new Board of Directors. A …See details»
More documents for SciRhom GmbH - Life-Sciences-Europe.com
SciRhom was founded and is led by a highly experienced management team with an excellent track record in antibody drug development that consists of Dr. Jens Ruhe, co-founder of U3 …See details»
SciRhom Announces Approval of First Clinical Trial Application for …
Jun 12, 2024 development organization, SciRhom has established a comprehensive preclinical pharmacology and toxicology data package for the lead development program, a robust and …See details»
SciRhom pulls in $70M for a new type of immune disease drug
Jul 9, 2024 As its name suggests, SciRhom is developing drugs aimed at a protein known as iRhom2 that’s involved in inflammation. iRhom2 helps regulate a key enzyme, known …See details»
SciRhom funding to be used for antibody drug known as SR-878
Jul 11, 2024 SciRhom was founded in 2016 at the Innovation and Startup Center (IZB) in Martinsried, Germany. The company works closely with its scientific founder, professor Carl …See details»
SciRhom Secures EUR 63 Million Series A Financing Round to …
SciRhom was founded with the mission to provide a new treatment paradigm for autoimmune diseases and potentially other indications by selectively addressing TACE/ADAM17, a master …See details»
SciRhom Raises EUR 63 Million in Series A to Boost iRhom2
Jul 10, 2024 SciRhom GmbH, a biopharmaceutical firm at the forefront of creating first-in-class therapeutic iRhom2 antibodies, has declared the successful conclusion of a EUR 63 million …See details»